Loading asset research
Ardelyx Inc. Common Stock
ARDXNasdaq · USD · StocksQuote as of · Exchange session not verified$3.58
-1.24%
Today
ARDX
Loading 1D prices…
Market cap
$924.3M
Volume
5.7M
52w high
$8.4052w low
$3.56Company profile
Ardelyx Inc. Common Stock
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Waltham, MA, United States
Employees
489
Fiscal year end
1231
CIK
1437402
Session & valuation
Open$3.65
Previous close$3.62
Day high$3.68
Day low$3.56
30-day avg. volume4.8M
Outstanding shares249.2M
Diluted EPS-$0.26
Latest annual period
P/E (trailing)-13.75
P/E (forward)11.96
Price / book5.99
Beta0.69
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| DSGNDesign Therapeutics Inc. Common Stock | $915.6M | $0.00 | — | -$1.22 | -1.01% | Buy |
| WVEWave Life Sciences Inc. Common Stock | $904.5M | $42.7M | -478.33% | -$1.21 | -1.82% | Buy |
| HELPCybin Inc. Common Stock | $947.6M | — | — | -$4.25 | +1.01% | Buy |
| IVAInventiva S.A. American Depository Shares | $949.6M | — | — | -$1.90 | -2.90% | Buy |
| OLMAOlema Pharmaceuticals Inc. Common Stock | $894.2M | $0.00 | — | -$1.87 | -4.30% | Buy |